A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA

NCT05939128 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
625
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca